26 research outputs found

    Morris water maze overtraining increases the density of thorny excrescences in the basal dendrites of CA3 pyramidal neurons

    Get PDF
    The hippocampus plays a fundamental role in spatial learning and memory. Dentate gyrus (DG) granular neurons project mainly to proximal apical dendrites of neurons in the CA3 stratum lucidum and also, to some extent, to the basal dendrites of CA3 pyramidal cells in the stratum oriens. The terminal specializations of DG neurons are the mossy fibers (MF), and these huge axon terminals show expansion in the CA3 stratum oriens after the animals undergo overtraining in the Morris Water Maze task (MWM). However, to our knowledge there are no reports regarding the possible changes in density of post-synaptic targets of these terminals in the basal dendrites of CA3 neurons after overtraining in the MWM. The purpose of this work was to study the density of thorny excrescences (TE) and other dendritic spine types (stubby, thin, and mushroom) in the CA3 stratum oriens in animals overtrained in the MWM for three consecutive days and in animals trained for only one day. Seven days after MWM training, the animals were sacrificed, and their brains removed and processed for rapid Golgi staining to visualize the different types of dendritic protrusions. Our results revealed that the relative quantity of stubby, thin, and mushroom dendritic spines did not change, regardless of amount of training. However, a significant increase in the density of TE was detected in the overtrained animals. These results strongly suggest that spatial water maze overtraining induces an increased density of MF–TE connections, which might be functionally relevant for long-term spatial memory formation.Fil: GĂłmez Padilla, EurĂ­dice. Universidad Autonoma de Queretaro.; MĂ©xicoFil: Bello Medina, Paola C.. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xicoFil: LeĂłn Jacinto, Uriel. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xicoFil: Orta Salazar, Erika. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xicoFil: Quirarte, Gina L.. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xicoFil: Ramirez Amaya, Victor. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - CĂłrdoba. Instituto de InvestigaciĂłn MĂ©dica Mercedes y MartĂ­n Ferreyra. Universidad Nacional de CĂłrdoba. Instituto de InvestigaciĂłn MĂ©dica Mercedes y MartĂ­n Ferreyra; Argentina. Universidad Autonoma de Queretaro.; MĂ©xicoFil: Prado AlcalĂĄ, Roberto A.. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xicoFil: DĂ­az Cintra, SofĂ­a. Universidad Nacional AutĂłnoma de MĂ©xico; MĂ©xic

    Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Get PDF
    This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic

    Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

    Get PDF
    Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

    Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

    Get PDF
    Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    Get PDF
    Supported by F. Hoffmann–La Roche

    Direct biohydrogen production from chitosan harvested microalgae biomass and an isolated yeast

    No full text
    \ua9 2024 Elsevier LtdThere is a bottleneck in recovery microalgae biomass from cultivations to recovery bioenergy the low metabolites yields achieved still lacks low operating cost. Optimization of the harvesting process such as coagulation-flocculation is crucial to find the conditions of a chemical compound for biomass and metabolites recovery and suitable or easy assimilation by microorganism for biohydrogen production. Dose, pH, flocculation velocity, flocculation and settling times are relevant factors that influence over biomass and metabolites recovery and define the requirements of the harvesting process in terms of invested energy. The aim of this study is to get the efficiency of biomass and biomolecules separation by using the response surface methodology for three chemical compounds such as ferric chloride, aluminum sulfate and chitosan. The design presented recovery efficiencies highest as 99 % for all the coagulants. A selection of coagulant conditions yields augmentation a carbohydrates content subsequently transformed to biohydrogen. The mix of microalgae and chitosan presented high carbohydrates increase or a low effect on carbohydrates determination in comparison to those harvested using other flocculants, where the microalgae biomass was washed because of precipitates formation. The biohydrogen produced from untreated harvested microalgae biomass with chitosan was of 1.958 \ub1 0.2 mmol/L using isolated indigenous yeast Candida sp. by using the chitosan concentration to recovery the maximum biomass concentration (0.02 g/L), was of 2.4 \ub1 0.1 mmol/L of H2. Under these conditions, the energy reduction was from 0.15 kWh/m3 to 1.2 kWh/m3, 35 % to >80 % less in comparison with other flocculants applied. In this context, the findings demonstrated that applying an organic flocculant for microalgae harvesting even lacking high biomass and carbohydrates yields, the biomass can be enriched and improved leading for a sustainable and direct route to produce a potential biofuel
    corecore